| Patents for C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780) |
|---|
| 01/22/2002 | US6340548 Organophotoreceptors for electrophotography featuring novel charge transport compounds |
| 01/22/2002 | CA2051460C Pharmaceutical compounds |
| 01/17/2002 | WO2002004440A1 Composition and antiviral activity of substituted indoleoxoacetic piperazine derivatives |
| 01/17/2002 | WO2002004412A2 Tyrosine derivatives as phosphatase inhibitors |
| 01/17/2002 | WO2002004402A1 Ester derivatives |
| 01/17/2002 | WO2002004401A1 PROCESS FOR THE PREPARATION OF β-AMINO ALCOHOLS IN SYN CONFIGURATION |
| 01/17/2002 | WO2002003995A2 Treatment of male sexual dysfunction |
| 01/17/2002 | WO2002003991A2 Use of substituted indole compounds for increasing nitric oxide synthase activity |
| 01/17/2002 | WO2002003977A2 Combinations of statins, estrogenic agents and optionally estrogens |
| 01/17/2002 | WO2002003975A2 Combinations of ssri and estrogenic agents |
| 01/17/2002 | WO2001055107A3 Aromatic amines and amides acting on the melanocortin receptors |
| 01/17/2002 | WO2001042211A3 Detection of transmembrane potentials by optical methods |
| 01/17/2002 | WO2001021589A3 Mono- and bis-indolylquinones and prophylactic and therapeutic uses thereof |
| 01/17/2002 | US20020006934 Phenyl-substituted imidazopyridines |
| 01/17/2002 | US20020006928 Phenyl-substituted indoles and indazoles |
| 01/17/2002 | US20020006922 Metalloprotease inhibitors |
| 01/17/2002 | DE10033337A1 Biphenylcarbonsäureamide, ihre Herstellung und ihre Verwendung als Arzneimittel Biphenylcarbonsäureamide, their preparation and their use as medicaments |
| 01/17/2002 | CA2415468A1 Ester derivatives |
| 01/17/2002 | CA2414938A1 Combinations of ssri and estrogenic agents |
| 01/17/2002 | CA2414112A1 Treatment of male sexual dysfunction |
| 01/17/2002 | CA2414111A1 Use of substituted indole compounds for increasing nitric oxide synthase activity |
| 01/17/2002 | CA2414060A1 Combinations of statins, estrogenic agents and optionally estrogens |
| 01/17/2002 | CA2413044A1 Composition and antiviral activity of substituted indoleoxoacetic piperazine derivatives |
| 01/16/2002 | EP1171442A1 Xanthine derivatives and analogs as cell signalling inhibitors |
| 01/16/2002 | EP1171416A1 3-bicycloaryl-2-aminomethyl bicycloalkanes as serotonine reuptake inhibitors |
| 01/16/2002 | CN1331730A Phthalimidyl azo pigments, method for producing same and utilisation thereof |
| 01/16/2002 | CN1331689A 4-and 5-alkynyloxindoles and 4-and 5-alkenyloxindoles |
| 01/16/2002 | CN1331683A 2-phenylbenzimidazoles and 2-phenylindoles, and prodn. and use thereof |
| 01/16/2002 | CN1331679A 3-azabicyclo [3.1.0] hexane derivatives as opiate receptors ligands |
| 01/16/2002 | CN1331678A Synthesis of phenolic monomers contg. imide or diimide moieties and high heat carbonate polymers prepared therefrom |
| 01/16/2002 | CN1331674A Sulfonamide hydroxamates |
| 01/16/2002 | CN1077887C Method for preparing antihypertensive and anticancer compound |
| 01/16/2002 | CN1077886C Amidino derivatives useful as nitric oxide synthase inhibitors |
| 01/15/2002 | US6339094 2-acylaminopropanamines as tachykinin receptor antagonists |
| 01/15/2002 | US6339087 For therapy of inflammatory or allergic diseases are selected from asthma, allergic rhinitis, hypersensitivity lung diseases, hypersensitivity pneumonitis, eosinophilic pneumonias, inflammatory bowel diseases, psoriasis, dermatitis |
| 01/15/2002 | US6339081 Composition and use |
| 01/10/2002 | WO2002003067A1 Methods for encoding combinatorial libraries |
| 01/10/2002 | WO2002002556A2 AZA-BRIDGED-BICYCLIC AMINO ACID DERIVATIVES AS α4 INTEGRIN ANTAGONISTS |
| 01/10/2002 | WO2002002513A1 Cyclopentyl-substituted glutaramide derivatives as inhibitors of neutral endopeptidase |
| 01/10/2002 | WO2002002512A2 Compounds to treat alzheimer's disease |
| 01/10/2002 | WO2002002507A1 2-hydroxy-5-amino-biphenyl-derivatives and oxidative hair colouring agents containing said compounds |
| 01/10/2002 | WO2002002488A2 Methods and compounds for modulating nuclear receptor coactivator binding |
| 01/10/2002 | WO2001023346A3 Process for phenylacetic acid derivatives |
| 01/10/2002 | US20020004522 Nervous system disorders |
| 01/10/2002 | US20020004219 Diagnosis of bacteria infections |
| 01/10/2002 | US20020004198 Detecting viricides; mix polypeptide samples, incubate with modulator of protein activity, monitor sample viricidal activity |
| 01/10/2002 | CA2415103A1 Methods and compounds for modulating nuclear receptor coactivator binding |
| 01/10/2002 | CA2415098A1 Methods for encoding combinatorial libraries |
| 01/10/2002 | CA2415088A1 Aza-bridged-bicyclic amino acid derivatives as .alpha.4 integrin antagonists |
| 01/10/2002 | CA2414881A1 Cyclopentyl-substituted glutaramide derivatives as inhibitors of neutral endopeptidase |
| 01/10/2002 | CA2410651A1 Compounds to treat alzheimer's disease |
| 01/10/2002 | CA2383577A1 2-hydroxy-5-aminobiphenyl derivatives and oxidative hair dyes containing these compounds |
| 01/09/2002 | EP1170288A2 Diphenylureum derivatives and their use as alpha2/5-HT2c antagonists |
| 01/09/2002 | EP1170273A1 Alkynic compounds, their use as monomers in vacuum deposition polymerisation, thin films formed from these polymers and their use in electroluminescent devices |
| 01/09/2002 | EP1169305A1 Indigoid bisindole derivatives |
| 01/09/2002 | EP1169294A2 Pharmaceutical compounds |
| 01/09/2002 | CN1330641A Crystalline forms of 3-(2,4-dichlorobenzyl)-2-methyl-N-(pentylsulfonyl)-3H-benzimidzole-5-carboxamide |
| 01/09/2002 | CN1330635A Method for producing 3-alkanoylindoles and 3-alkylindoles |
| 01/08/2002 | US6337404 Diamine hole transport agent and organic electroluminescent device containing same |
| 01/08/2002 | US6337399 Condensation of isoindole with borate group with quinolone carboxylic acid |
| 01/08/2002 | US6337350 Inhibitors of formation of advanced glycation endproducts (AGEs) |
| 01/08/2002 | US6337344 Anticoagulants and enzyme inhibitors for cardiovascular disorders |
| 01/08/2002 | US6337064 Used as contrast agent in magnetic resonance imaging, medical diagnosis |
| 01/08/2002 | CA2080140C Photodynamic plant defoliants and chlorophyll biosynthesis modulators |
| 01/03/2002 | WO2002001653A2 Organic light emitting diode devices using aromatic amine compounds with high and tunable glass transition temperatures |
| 01/03/2002 | WO2002000650A2 Novel compounds possessing antibacterial, antifungal or antitumor activity |
| 01/03/2002 | WO2002000621A1 Compounds exhibiting x-type spla2 inhibiting effect |
| 01/03/2002 | WO2002000612A1 Glucagon antagonists/inverse agonists |
| 01/03/2002 | WO2002000606A1 Biphenyl compound |
| 01/03/2002 | WO2002000257A1 Remedies for alzheimer's disease |
| 01/03/2002 | WO2002000256A1 Remedies for cirrhosis |
| 01/03/2002 | WO2002000216A1 Carvedilol |
| 01/03/2002 | WO2001070693A3 Difluorobutyric acid derivatives and their use as metalloprotease inhibitors |
| 01/03/2002 | WO2001045689A3 Indolinone derivatives for modulation of c-kit tyrosine protein kinase |
| 01/03/2002 | WO2000061549A3 Pharmaceutical compounds |
| 01/03/2002 | US20020002286 Solid phase synthesis; reacting amino resin with diketone; then primary amine and1,4-benzoquinone; releasing indole product |
| 01/03/2002 | US20020002199 Suitable for treating type I diabetes, type II diabetes, impaired glucose tolerance, insulin resistance or obesity |
| 01/03/2002 | US20020002190 Antidiabetic agents increasing the expression of glucokinase (GK) to improve glucose tolerance; increase in glucose exposure coupled through GK in beta-cells to increase insulin secretion and in hepatocytes to increase glycogen deposition |
| 01/03/2002 | US20020002188 Heterocyclic amides/imides as inhibitors of tumor necrosis factor alpha and nuclear factor kappa B and phosphodi-esterases III and IV; used to combat cachexia, endotoxic shock, retrovirus replication and asthma; antiinflammatory |
| 01/03/2002 | US20020002161 5-HT ligands used to treat central nervous system disorders |
| 01/03/2002 | US20020002152 Methionine aminopeptidase type 2 inhibitors; n'-((2S,3R)-3-amino-2-hydroxy-5-(isopropylsulfanyl)pentanoyl)-3-chloro benzoyl hydrazide |
| 01/03/2002 | DE10030375A1 Verwendung von MTP-Inhibitoren zur Senkung von ppTRL Use of MTP inhibitors to reduce ppTRL |
| 01/03/2002 | CA2414512A1 Novel compounds possessing antibacterial, antifungal or antitumor activity |
| 01/03/2002 | CA2413702A1 Carvedilol |
| 01/03/2002 | CA2411552A1 Glucagon antagonists/inverse agonists |
| 01/02/2002 | EP1166783A2 Tetrahydrobenz[CD]indole-6-carboxamides for treating sexual dysfunction |
| 01/02/2002 | EP1165693A2 Squaraine dyes |
| 01/02/2002 | EP1165517A1 N-benzimidazolylmethyl- and n-indolylmethyl-benzamides and their use as crf modulators |
| 01/02/2002 | EP1165516A2 Heterocyclic urea and related compounds useful as anti-inflammatory agents |
| 01/02/2002 | EP1165515A1 Pyridine-2,3-dicarboxylic acid diamides |
| 01/02/2002 | EP1165514A1 3-(anilinomethylene) oxindoles as protein tyrosine kinase and protein serine/threonine kinase inhibitors |
| 01/02/2002 | EP1165513A1 Indolinone compounds as kinase inhibitors |
| 01/02/2002 | EP1165512A2 Method for arylating aza-heterocycles with activated aromatic compounds in the presence of cesium carbonate |
| 01/02/2002 | EP1165511A2 Method of producing heterocyclic carbamates from aza-heterocyclic compounds and carbon dioxide |
| 01/02/2002 | EP1165505A1 Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds |
| 01/02/2002 | EP1165501A1 Alkenyl- and alkynyl-containing metalloprotease inhibitors |
| 01/02/2002 | EP1165496A1 Substituted aniline compounds |
| 01/02/2002 | EP1165064A2 Novel inhibitors of formation of advanced glycation endproducts (age's) |
| 01/02/2002 | EP0815079B1 Method for the preparation of a n-alkoxy-(tetra- or hexahydro)-phthalimide and method for the preparation of a n-alkoxyamine |
| 01/02/2002 | EP0731091B1 2-oxoindoline derivatives as cholecystokinin receptor antagonists |